Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation

BACKGROUND AND PURPOSE: Nutrient overload leads to obesity and insulin resistance. Pioglitazone, a selective peroxisome proliferator-activated receptor (PPAR)γ agonist, is currently used to manage insulin resistance, but the specific molecular mechanisms activated by PPARγ are not yet fully understo...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Collino, Massimo, Aragno, Manuela, Castiglia, Sara, Miglio, Gianluca, Tomasinelli, Chiara, Boccuzzi, Giuseppe, Thiemermann, Christoph, Fantozzi, Roberto
Materialtyp: Artigo
Språk:Inglês
Publicerad: Blackwell Publishing Ltd 2010
Ämnen:
Research Papers with Commentaries
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2958635/
https://ncbi.nlm.nih.gov/pubmed/20233219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2010.00671.x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk